QurAlis
Phase 1At QurAlis, we consider ourselves “neuro pioneers” because we are driven to explore the deepest aspects of human neurology in order to find the treatments
Founded
2018
Focus
Small Molecules
About
At QurAlis, we consider ourselves “neuro pioneers” because we are driven to explore the deepest aspects of human neurology in order to find the treatments
Funding History
3Total raised: $138.5M
Series B$88MLS Polaris Innovation FundJan 15, 2022
Series A$42MLS Polaris Innovation FundOct 15, 2020
Seed$8.5MMPM CapitalJun 15, 2018
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile